Forbes6d
Charlotte’s Web Founder Aims For FDA Approval Of Autism Spectrum Disorder Drug
Joel Stanley, former CEO of Charlotte’s Web, is part of a joint effort to achieve approval from the FDA for a novel treatment for the symptoms of autism spectrum disorder (ASD). Stanley is the ...
US FDA OKs monthly maintenance dosing for Eisai/Biogen's Alzheimer's drug
The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...
The American Journal of Managed Care6d
FDA Approves Mirikizumab for Crohn Disease
Omvoh's approval provides a new treatment option for Crohn's disease patients, especially those unresponsive to existing therapies. The FDA granted approval to Eli Lilly and Company’s ...
PBS4d
The FDA banned Red 3 food coloring. A scientist explains the dye’s history and health risks
Over 35 years after the first study linking the artificial food dye Red 3 to thyroid cancer in rats was published, the U.S.
FDA bans Red 3 dye from food and drugs. A scientist explains the artificial color's health risks and long history
Red 3—also called FD&C Red No. 3, erythrosine or E127—has been widely used in food, cosmetics and pharmaceuticals since its ...
CNET3d
FDA Finally Bans Red Dye No. 3: What You Need to Know
The US Food and Drug Administration announced this month that it's effectively banning Red No. 3, the controversial ...
pharmaphorum1d
Alnylam grabs FDA approval for its second amyloidosis therapy
Four years after getting the first drug approved by the FDA to treat rare disease hereditary ATTR amyloidosis, Alnylam has got the go-ahead for a second – Amvuttra – which has a simpler ...
Scientific American5d
What’s in ZYN, the FDA-Authorized Nicotine Pouch? Is It Harmful?
ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some ...
The Punch Newspapers6d
Govt approves N4bn cash transfer for vulnerable households
The Federal Government has approved N4bn for conditional cash transfers to vulnerable households in Nigeria. During the launch of the 2025 Nigeria Humanitarian Needs and Response Plan at the ...
FiercePharma3d
Regulatory tracker: Merck's Welireg picks up FDA priority review in rare tumor bid
The partners expect the FDA to complete its review process in the fourth quarter of 2025. Simponi was first approved in 2009 and treats a variety of inflammatory conditions including rheumatoid ...
pharmaphorum5d
Amicus' oral Fabry disease drug approved in US
Amicus Therapeutics’ first oral drug for the rare condition Fabry disease has been approved by the FDA, giving patients an alternative to conventional injected enzyme replacement therapy.